Medications for Constipation
The first-line pharmacological treatment for constipation is polyethylene glycol (PEG 3350), which is recommended at a dose of 17g daily dissolved in 4-8 ounces of liquid, with no clear maximum dose and demonstrated durable response over 6 months. 1, 2
Classification of Constipation Medications
Osmotic Laxatives
Polyethylene glycol (PEG 3350)
- Initial dose: 17g daily
- Cost: $10-45 monthly
- Mechanism: Osmotic laxative
- Advantages: Durable response over 6 months, no clear maximum dose
- Side effects: Bloating, abdominal discomfort, cramping 1
Magnesium oxide
- Initial dose: 400-500mg daily
- Cost: <$50 monthly
- Caution: Use carefully in renal insufficiency
- Note: Previous studies used 1,000-1,500mg daily 1
Lactulose
- Initial dose: 15g daily
- Cost: <$50 monthly
- Note: Only osmotic agent studied in pregnancy
- Side effects: Bloating and flatulence may limit use 1
Stimulant Laxatives
Bisacodyl and sodium picosulfate
- Initial dose: Bisacodyl 5mg daily
- Maximum dose: 10mg orally daily
- Cost: <$50 monthly
- Recommended for: Short-term use or rescue therapy
- Side effects: Cramping, abdominal discomfort
- Caution: Prolonged use can cause diarrhea and electrolyte imbalance 1
Senna
- Initial dose: 8.6-17.2mg daily
- Cost: <$50 monthly
- Note: Also present in many laxative teas
- Maximum: Recommended maximum is 4 tablets twice per day 1
Intestinal Secretagogues
Lubiprostone
Linaclotide
- Initial dose: 72-145μg daily
- Maximum dose: 290μg daily
- Cost: $523 monthly
- Benefits: May help with abdominal pain
- Side effects: Diarrhea 1
Plecanatide
- Dose: 3mg daily
- Cost: $526 monthly
- Side effects: Diarrhea 1
5-HT4 Agonists
- Prucalopride
- Dose: 1-2mg daily
- Maximum dose: 2mg daily
- Cost: $563 monthly
- Benefits: May help with abdominal pain
- Side effects: Headaches and diarrhea 1
Treatment Algorithm
Step 1: Start with non-pharmacological interventions
- Increase fluid intake
- Increase dietary fiber (14g/1,000 kcal intake per day)
- Increase physical activity within patient limits
- Ensure privacy and comfort for defecation 2
Step 2: First-line pharmacological treatment
- PEG 3350 (17g daily) - most effective first-line agent 1, 2
- Can be combined with fiber supplements if needed
Step 3: If inadequate response to PEG
- Add or switch to another osmotic laxative (lactulose or magnesium salts)
- Consider adding a stimulant laxative (bisacodyl, sodium picosulfate, or senna) 1
Step 4: For refractory constipation
- Consider prescription medications:
- Lubiprostone (24μg twice daily)
- Linaclotide (72-145μg daily)
- Plecanatide (3mg daily)
- Prucalopride (1-2mg daily) 1
Special Considerations
Opioid-Induced Constipation
- Prophylactic bowel regimen recommended
- PEG 3350 as first-line treatment
- Add stimulant laxative if PEG alone is insufficient
- Avoid bulk laxatives (psyllium) for opioid-induced constipation
- Consider methylnaltrexone for opioid-induced constipation (0.15 mg/kg subcutaneously every other day) 1, 2
Palliative Care Context
For patients with months to weeks of life expectancy:
- Discontinue non-essential constipating medications
- Rule out impaction and obstruction
- Add and titrate bisacodyl 10-15mg daily to TID
- Goal: One non-forced bowel movement every 1-2 days 1
For patients with weeks to days of life expectancy:
- Increase dose of laxative ± stool softener (senna ± docusate, 2-3 tablets BID-TID) 1
Clinical Pearls and Pitfalls
Pitfall: Relying solely on fiber supplementation for all types of constipation
- Solution: While fiber can be effective for many patients, those with slow transit constipation or defecatory disorders often do not respond well to fiber alone 4
Pitfall: Not considering underlying causes of constipation
- Solution: Rule out impaction, obstruction, hypercalcemia, hypokalemia, hypothyroidism, diabetes mellitus, and medication effects 1
Pitfall: Inadequate dosing of laxatives
- Solution: Titrate doses based on symptom response and side effects 1
Pitfall: Not monitoring for electrolyte imbalances with prolonged stimulant laxative use
- Solution: Use stimulant laxatives for short-term or rescue therapy when possible 1
Pitfall: Overlooking the need for specialized referral in refractory cases
- Solution: Consider referral for patients over 45 years with atypical symptoms, short history, or persistent symptoms despite treatment 2